Did you know?

Oct 10, 2023 · ANDOVER, Mass., Oct. 10, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... Back to TMDX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following …ANDOVER, Mass., Aug. 3, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant therapy for patients with ...TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure ...ANDOVER, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for ...TMDX stock has a Moderate Buy consensus rating based on two Buy and one Hold recommendations. However, due to the recent rally in its stock price, analysts’ average price target of $66.67 ...ANDOVER, Mass., Aug. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...NASDAQ: TMDX TransMedics Group. Market Cap. $2B. Today's Change (2.92%) $1.95. Current Price. $68.70. Price as of November 17, 2023, 4:00 p.m. ET. ... (TMDX 2.92%). This high-growth stock has been ...With revenue growth of 69% y/y in 2018 and a long list of institutional investors financing TransMedics Group (NASDAQ:TMDX), market participants should review the company’s technology.Having ...Stock Exchange NASDAQ Ticker Symbol TMDX Full Company Profile Financial Performance In 2022, TMDX's revenue was $93.46 million, an increase of …TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028. ANDOVER, Mass. , May 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st... 7 months ago - PRNewsWire.TransMedics (TMDX) reported $66.43 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 158.7%. EPS of -$0.12 for the same period compares to -$0.25 a ...TransMedics Group Inc (Symbol: TMDX) saw options trading volume of 3,088 contracts, representing approximately 308,800 underlying shares or approximately 85.5% of TMDX's average daily trading ...Founded in 1998 by President and CEO Waleed Hassanein, TransMedics Group (TMDX 3.88%) has quickly become one of the easiest stocks to root for of our time by revolutionizing the organ donation and ...TransMedics Group, Inc. (NASDAQ:TMDX) is a Massachusetts-based commercial-stage medical technology company, engaged in transforming organ transplant therapy for end-stage organ failure patients in ...TransMedics Group (NASDAQ:TMDX) provides organ preservation technology and is a leader in normothermic machine perfusion.Its FDA-approved Organ Care System replicates the body’s physiologic ...NASDAQ: TransMedics Group Inc (TMDX) = 75.68 USD. Provided by Alpha Vantage. TransMedics Group Inc stock (TMDX) in USD. 1 TMDX = 75.68 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Abra uma conta. TransMedics Group Inc stock performance at a glance.Based on analysts offering 12 month price targets for TMDX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Nasdaq. 14,258.49-23.27 (-0.16%) ... (NASDAQ:TMDX) future prospects. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for ...ANDOVER, Mass., Aug. 3, 2022 /PRNewswire/ -- TransMedics Group, Inc. Jul 22, 2022 · Find the latest SEC Filings d ANDOVER, Mass., Nov. 11, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...Charles Schwab Investment Management Inc. raised its position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 3.1% in the 2nd quarter, … (RTTNews) - The following are some of the healthcare companies tha ANDOVER, Mass., Sept. 7, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... TransMedics Group, Inc. 01 Mar, 2021, 16:15 ET.

("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 5, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 105,119 shares of its common stock and an …Find the latest dividend history for TransMedics Group, Inc. Common Stock (TMDX) at Nasdaq.com.ANDOVER, Mass., April 21, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...TransMedics Group (NASDAQ: TMDX) fool.com - August 19 at 11:22 PM: Spouting Rock Asset Management LLC Lowers Stake in TransMedics Group, Inc. (NASDAQ:TMDX) marketbeat.com - August 18 at 9:41 AM: TransMedics (TMDX) Acquires Summit Aviation for Organ Transplant finance.yahoo.com - August 17 at 6:32 PMTMDX NASDAQ. TMDX NASDAQ. TMDX NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 79.20 0.00 0.00%. The 5 analysts offering 1 year price forecasts for TMDX have a max estimate of — and a min estimate of —.

२०२३ अगस्ट २ ... (NASDAQ: TMDX), including its EVOSS heart and lung and LifeCradle heart perfusion assets. BTL will use the proceeds from the divestiture of ...August 17, 2023 at 8:21 AM · 3 min read. TransMedics Group, Inc. TMDX, in a strategic move to revolutionize organ transplant therapy, has successfully concluded the acquisition of Summit Aviation ...TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. TransMedics Group, Inc. (NASDAQ:TMDX) is a. Possible cause: On the other hand TransMedics Group, Inc. (NASDAQ:TMDX) is the least popular one with onl.